DS-1040

N/A

Report date: 2024/08/13 20:00:09
NME

Base Information

Drug NameDS-1040
Drug Alias NameDS-1040DS-1040b
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCarboxypeptidase B2 isoform A inhibitors
TargetsCarboxypeptidase B2 isoform A
Therapy Area/IndicationsIschemic StrokeEmbolism and ThrombosisPulmonary Embolism
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUnited States +[14] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDaiichi Sankyo Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaiichi Sankyo Co Ltd
Active IndicationsN/A
Inactive IndicationsIschemic StrokeEmbolism and ThrombosisPulmonary Embolism

Other Information

ATC CodeN/A
Related LinksN/A